Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

(Mark One)

 

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2003

 

or

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from           to          

 

Commission File Number: 33-7106-A

 

NATURADE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

23-2442709

(State or other jurisdiction of incorporation or
organization)

 

(I. R. S. Employer Identification No.)

 

 

 

14370 Myford Rd., Irvine, California 92606

(Address of principal executive offices) (Zip code)

 

(714) 573-4800

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes o   No ý

 

Indicate the number of shares outstanding of the registrant’s common stock, as of the latest practicable date: 44,533,886 shares as of October 30, 2003.

 

 



 

FORM 10-Q
QUARTERLY REPORT

Quarter Ended September 30, 2003
TABLE OF CONTENTS

 

PART I:

FINANCIAL INFORMATION

Item 1.

Financial Statements

 

Balance Sheets as of September 30, 2003 (unaudited) and December 31, 2002 (audited)

 

Statements of Operations for the three and nine month periods ended September 30, 2003 (unaudited) and September 30, 2002 (unaudited)

 

Statements of Cash Flows for the nine months ended September 30, 2003 (unaudited) and September 30, 2002 (unaudited)

 

Notes to Financial Statements

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Item 4

Controls and Procedures

PART II:

OTHER INFORMATION

Item 1.

Legal Proceedings

Item 2.

Changes in Securities and Use of Proceeds

Item 3.

Defaults Upon Senior Securities

Item 4.

Submission of Matters to a Vote of Security Holders

Item 5.

Other Information

Item 6.

Exhibits and Reports on Form 8-K

SIGNATURES

 

2



 

NATURADE, INC.

 

Balance Sheets

As of September 30, 2003 and December 31, 2002

 

 

 

September 30, 2003

 

December 31, 2002

 

 

 

(Unaudited)

 

(Audited)

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

186,030

 

$

722,583

 

Accounts receivable, net

 

1,331,542

 

1,427,058

 

Inventories, net

 

1,081,558

 

1,689,131

 

Prepaid expenses and other current assets

 

306,040

 

105,135

 

Total current assets

 

2,905,170

 

3,943,907

 

 

 

 

 

 

 

Property and equipment, net

 

175,738

 

228,723

 

Other assets

 

48,549

 

49,594

 

Total assets

 

$

3,129,457

 

$

4,222,224

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

2,135,529

 

$

2,750,477

 

Accrued expenses

 

799,041

 

604,194

 

Current portion of Note Payable to Related Party

 

213,837

 

202,345

 

Current portion of long-term debt

 

1,368,227

 

1,816,662

 

Total current liabilities

 

4,516,634

 

5,373,678

 

 

 

 

 

 

 

Long-term portion of Notes Payable to Related Parties, less current maturities

 

450,000

 

0

 

 

 

 

 

 

 

Long-term debt, less current maturities

 

13,882

 

37,735

 

 

 

 

 

 

 

Total Liabilities

 

4,980,516

 

5,411,413

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

 

 

 

 

REDEEMABLE CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

Redeemable convertible preferred stock, Series B, less discount of $1,330,456 at September 30, 2003, and $1,714,286 at December 31, 2002, par value $0.0001 per share: authorized 50,000,000 shares; issued and outstanding, 13,540,723 at September 30, 2003 and December 31, 2002 ($2,000,000 redemption value)

 

639,942

 

256,112

 

 

 

 

 

 

 

WARRANT

 

500,000

 

500,000

 

 

 

 

 

 

 

STOCKHOLDERS’ DEFICIT:

 

 

 

 

 

Common stock, par value $0.0001 per share; authorized, 100,000,000 shares; issued and outstanding, 44,533,886 at September 30, 2003 and December 31, 2002

 

4,453

 

4,453

 

Preferred stock, Series A, par value $0.0001 per share; authorized, 2,000,000 shares; issued and outstanding, 0 at June 30, 2003 and December 31, 2002

 

0

 

0

 

Non-Voting Common stock, par value $0.0001 per share; authorized, 2,000,000 shares; issued and outstanding, 117,284 at September 30, 2003 and December 31, 2002

 

12

 

12

 

 

 

 

 

 

 

Additional paid-in capital

 

18,987,458

 

18,987,458

 

Accumulated deficit

 

(21,982,924

)

(20,937,224

)

Total stockholders’ deficit

 

(2,991,001

)

(1,945,301

)

Total liabilities and stockholders’ deficit

 

$

3,129,457

 

$

4,222,224

 

 

See accompanying notes to financial statements.

 

3



 

NATURADE, INC

 

Statements of Operations for the Three Months and Nine Months

Ended September 30, 2003 and September 30, 2002

 

 

 

Three Months
Ended
September 30, 2003

 

Three Months
Ended
September 30, 2002

 

Nine Months
Ended
September 30, 2003

 

Nine Months
Ended
September 30, 2002

 

 

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

3,767,767

 

$

3,597,557

 

$

11,716,506

 

$

10,205,842

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

1,974,691

 

2,017,708

 

6,294,995

 

5,877,014

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

1,793,076

 

1,579,849

 

5,421,511

 

4,328,828

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

1,958,255

 

2,018,420

 

5,900,736

 

6,006,981

 

Depreciation and amortization

 

18,723

 

20,843

 

56,774

 

65,928

 

 

 

 

 

 

 

 

 

 

 

Total operating costs and expenses

 

1,976,978

 

2,039,263

 

5,957,510

 

6,072,909

 

 

 

 

 

 

<